Display options
Cite
Vasiltseva OY, Vitt KN, Cherniavsky AM. [Features of pulmonary thromboembolism in women]. Kardiologiia. 2021;61(11):89-97doi: 10.18087/cardio.2021.11.n1147.
Vasiltseva, O. Y., Vitt, K. N., & Cherniavsky, A. M. (2021). [Features of pulmonary thromboembolism in women]. Kardiologiia, 61(11), 89-97. https://doi.org/10.18087/cardio.2021.11.n1147
Vasiltseva, O Ya, et al. "[Features of pulmonary thromboembolism in women]." Kardiologiia vol. 61,11 (2021): 89-97. doi: https://doi.org/10.18087/cardio.2021.11.n1147
Vasiltseva OY, Vitt KN, Cherniavsky AM. [Features of pulmonary thromboembolism in women]. Kardiologiia. 2021 Nov 30;61(11):89-97. doi: 10.18087/cardio.2021.11.n1147. Russian. PMID: 34882082.
Copy Download .nbib Format: NLM
Share it on

Kardiologiia. 2021 Nov 30;61(11):89-97. doi: 10.18087/cardio.2021.11.n1147.

[Features of pulmonary thromboembolism in women].

Kardiologiia

[Article in Russian]
O Ya Vasiltseva, K N Vitt, A M Cherniavsky

Affiliations

  1. National Medical Research Center named after acad. E.N. Meshalkin, Novosibirsk.
  2. Tomsk National Research Medical Center, Russian Academy of Sciences, Tomsk.

PMID: 34882082 DOI: 10.18087/cardio.2021.11.n1147

Abstract

Pulmonary artery embolism (PAE) is usually a diagnosis of exclusion. Verification of a more common pathology takes time, which may become critical for treatment of pulmonary embolism and saving the patient's life. Since PAE is an acute disease, the time window for medical care largely determines the prognosis. Therefore, the differential diagnostic process should include thromboembolism already at the first visit. It is important to determine risk factors for PAE taking into account the patient's personality and gender. Obtained data may help the physician to determine quickly the expedience of visualizing studies, such as ventilation/perfusion scintigraphy, angiopulmonography, computed tomographic angiopulmonography. For women, it is important to collect specific information, such as the presence of large uterine fibroids, use of combined oral contraceptives or hormonal replacement therapy; to ask how long ago the patient had pregnancy and delivery, whether she has thrombophilia or oncological diseases.

Publication Types